View in EDS HTML Full Text PDF Full Text

GM-CSF promotes pro-inflammatory macrophage activation associated with Akt/mTOR signaling during experimental colitis.

Saved in:
Bibliographic Details
Title: GM-CSF promotes pro-inflammatory macrophage activation associated with Akt/mTOR signaling during experimental colitis.
Authors: Shen S; Department of Gastroenterology, West China Hospital, Sichuan University, Chengdu, China.; Centre for Inflammatory Bowel Disease, West China Hospital, Sichuan University, Chengdu, China.; Laboratory of Inflammatory bowel disease, Institute of Immunology and Inflammation, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, China., Chen K; Department of Gastroenterology, West China Hospital, Sichuan University, Chengdu, China.; Centre for Inflammatory Bowel Disease, West China Hospital, Sichuan University, Chengdu, China.; Laboratory of Inflammatory bowel disease, Institute of Immunology and Inflammation, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, China., Li L; Department of Gastroenterology, West China Hospital, Sichuan University, Chengdu, China.; Centre for Inflammatory Bowel Disease, West China Hospital, Sichuan University, Chengdu, China.; Laboratory of Inflammatory bowel disease, Institute of Immunology and Inflammation, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, China., Jiang M; Department of Gastroenterology, West China Hospital, Sichuan University, Chengdu, China.; Centre for Inflammatory Bowel Disease, West China Hospital, Sichuan University, Chengdu, China.; Laboratory of Inflammatory bowel disease, Institute of Immunology and Inflammation, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, China., Jia Y; Laboratory of Inflammatory bowel disease, Institute of Immunology and Inflammation, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, China., Bai X; Laboratory of Human Disease and Immunotherapies, West China Hospital, Sichuan University, Chengdu, China.; Institute of Immunology and Inflammation, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, China., Zeng Z; Department of Gastroenterology, West China Hospital, Sichuan University, Chengdu, China.; Centre for Inflammatory Bowel Disease, West China Hospital, Sichuan University, Chengdu, China.; Laboratory of Inflammatory bowel disease, Institute of Immunology and Inflammation, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, China., Ma C; Department of Gastroenterology, West China Hospital, Sichuan University, Chengdu, China.; Centre for Inflammatory Bowel Disease, West China Hospital, Sichuan University, Chengdu, China.; Laboratory of Inflammatory bowel disease, Institute of Immunology and Inflammation, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, China., Dang Y; Department of Gastroenterology, West China Hospital, Sichuan University, Chengdu, China.; Centre for Inflammatory Bowel Disease, West China Hospital, Sichuan University, Chengdu, China.; Laboratory of Inflammatory bowel disease, Institute of Immunology and Inflammation, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, China., Hu K; Department of Gastroenterology, West China Hospital, Sichuan University, Chengdu, China.; Centre for Inflammatory Bowel Disease, West China Hospital, Sichuan University, Chengdu, China.; Laboratory of Inflammatory bowel disease, Institute of Immunology and Inflammation, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, China., Chen Y; Laboratory of Human Disease and Immunotherapies, West China Hospital, Sichuan University, Chengdu, China.; Institute of Immunology and Inflammation, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, China., Zhang W; Laboratory of Human Disease and Immunotherapies, West China Hospital, Sichuan University, Chengdu, China.; Institute of Immunology and Inflammation, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, China., Miao Z; Laboratory of Human Disease and Immunotherapies, West China Hospital, Sichuan University, Chengdu, China.; Institute of Immunology and Inflammation, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, China., Chen L; Department of Gastroenterology, Suining Central Hospital, Suining, Sichuan, China., Zhang H; Department of Gastroenterology, West China Hospital, Sichuan University, Chengdu, China.; Centre for Inflammatory Bowel Disease, West China Hospital, Sichuan University, Chengdu, China.; Laboratory of Inflammatory bowel disease, Institute of Immunology and Inflammation, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, China.
Source: Frontiers in immunology [Front Immunol] 2026 Jun 26; Vol. 17, pp. 1799536. Date of Electronic Publication: 2026 Jun 26 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1664-3224
DOI:10.3389/fimmu.2026.1799536